Testosterone Replacement Drug Cases Consolidated
June 12, 2014
On June 6, 2014, the United States Judicial Panel on Multidistrict Litigation (“Panel”) decided to consolidate in the federal court in Chicago about 45 federal testosterone replacement drug cases pending throughout the United States against Abbott Laboratories (“Abbott”) and [...]
Continue Reading
FDA Issues Testosterone Therapy Safety Alert
February 2, 2014
On January 31, 2014, the FDA issued a Safety Announcement regarding FDA-approved testosterone products. The FDA’s alert concerns the risk of stroke, heart attack, and death in men taking testosterone products that the FDA had previously approved; two recent studies suggest an increased ris[...]
Continue Reading
